Setiptiline
| Setiptiline | |
|---|---|
| Salts [] | |
|---|---|
| Setiptiline maleate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 261.40 g/mol [1] |
| Predicted LogP | 3.3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C19H19N |
| IUPAC name | 4-methyl-4-azatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),2(7),8,10,12,15,17-heptaene |
| SMILES | CN1CCC2=C(C1)C3=CC=CC=C3CC4=CC=CC=C24 |
| InChI | InChI=1S/C19H19N/c1-20-11-10-18-16-8-4-2-6-14(16)12-15-7-3-5-9-17(15)19(18)13-20/h2-9H,10-13H2,1H3 |
| InChIKey | GVPIXRLYKVFFMK-UHFFFAOYSA-N |
| CAS number | 57262-94-9 |
| UNII | 7L38105Z6E |
| PubChem CID | 5205 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | Oral |
Setiptiline (also known as Org-8282, Setiptilina, Org 8282, Setiptilinum, Mo 8282, Mo-8282, 13b,4a-carba-mianserin, 1,2,3,4-tetrahydro-2-methyl-9H-dibenzo(3,4-6,7)cyclohepta(1,2-C)pyridine, 260-653-4 or 2,3,4,9-Tetrahydro-2-methyl-1H-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine) is a substance of the phenylpropylamine and phenethylamine class.
Chemistry
Salts []
Stereochemistry []
Setiptiline is achiral.
Druglikeness
Lipinski's rule of five
Setiptiline matches Lipinski's rule of five.Pharmacology
Mechanism of action []
Setiptiline is an antagonist at the α2 adrenergic receptor and at serotonin receptors. The antagonism of the α2 receptors likely relieves presynaptic inhibition of adrenergic neurotransmission, allowing for greater and longer sustained release of noradrenaline into the synapse. The antagonism of serotonin receptors may produce an upregulation of the receptors leading to an eventual increase in serotonergic signalling. The actual physiological mechanisms behind the antidepressant effect of setiptiline is unknown but the listed possibilities exist as likely explanations. [1]
Interactions []
Legal status []
- Other: Setiptiline is a Rx-only.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5205, Setiptiline. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5205
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Setiptiline. UNII: 7L38105Z6E. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/7L38105Z6E
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 18:38:35 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 18:38:31 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 18:38:30 |
| gsrs | ok | 2026-11-20 18:38:32 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0258262) | 2026-11-20 18:38:31 |
| kegg | ok | 2026-11-20 18:38:32 |
| pubchem | ok | 2026-11-20 18:38:30 |
| missing (no r/tripreports posts mention it) | 2026-11-20 18:38:30 | |
| sider | missing (not in SIDER) | 2026-11-20 18:38:30 |
| structure | ok | 2026-11-20 18:38:30 |
| wikipedia | ok | 2026-11-20 18:38:31 |